Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,252 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,462
Recruiting: 819
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 951–958 of 958 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00108875	Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer	unknown	Phase 1 / Phase 2	70	Julius-Maximilians UniversityOTHER	1	Jul 28, 2006	clinicaltrials
NCT00199680	Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer	unknown	Phase 2	42	University Hospital, LimogesOTHER	1	Feb 1, 2006	clinicaltrials